She will take on the role of director of veterinary science.
Professor Jacqui Matthews has been appointed as director of veterinary science for Austin Davis Biologics (ADB), beginning on 14 November 2022.
The company deals in veterinary diagnostics and parasitology research, particularly in equine health.
In her capacity as director of veterinary science, Professor Matthews will lead research and development activities, and will provide advice and support to clients who use the diagnostic test services through the use of webinars and training activities.
Dr Corrine Austin, founder and managing director of ABD, welcomed Professor Matthews to the team: “We are thrilled that Professor Matthews is joining our family-run veterinary diagnostic company.
“Her input to ADB’s research programmes, as well as the wider equine parasitology field, is highly valued.”
After originally qualifying as a veterinary surgeon, Professor Matthews moved into the field of academia, and for 25 years has become renowned for her work in equine parasitology.
Professor Matthews is the inventor of the small redworm blood test, and has published over 140 peer-reviewed papers.
Discussing her new position, Professor Matthews said: “I am absolutely delighted to be joining ADB and given this opportunity to support and promote evidence based helminth control in horses in the UK and overseas.
“I am also really looking forward to bringing more innovative diagnostics to the market to support animal health”.
Dr Austin added: “Not only do we have a busy future research program, but we hold a lot of information that hasn’t yet been published; Jacqui’s new position within ADB will accelerate future research as well dissemination of our existing research data.”
Image (C) Austin Davis Biologics
Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.
